Back to News
Market Impact: 0.2
RELX Highlights AI Push as Elsevier STM Growth Accelerates to 6%
Source: marketbeat.com
Corporate Guidance & OutlookArtificial IntelligenceCompany FundamentalsHealthcare & Biotech
Relx’s Scientific, Technical & Medical division is targeting continued improvement in long-term revenue growth. Its stated drivers are higher-value research and healthcare decision-support products, expanded publishing volumes, and AI-enabled tools; the article provides no quantified targets or timeframe beyond the long term.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.20
Ticker Sentiment
RELX0.35
More News
- What Wall Street billionaires are saying about Democrats' midterm sweep
- NextDC shares surge 43% after Goodman, Digital Realty stake purchases
- Voters rebuff data centers in every ballot measure except one during the 2026 midterms
- Asian chip stocks slide as disappointing Qualcomm, Arm earnings weigh
- Oil and data centre stocks sink after US midterms
- Snap shares fall over 10% on third-quarter earnings miss